Pakistan Refinery Limited (PSX:PRL)

Aerovate Therapeutics Revenue

Pakistan Refinery had revenue of 67.08B PKR in the quarter ending March 31, 2025, with 35.64% growth. This brings the company's revenue in the last twelve months to 309.86B, up 2.06% year-over-year. In the fiscal year ending June 30, 2024, Pakistan Refinery had annual revenue of 305.54B with 16.68% growth.

• Revenue (ttm): 309.86B
• Revenue Growth: +2.06%
• P/S Ratio: 0.07
• Revenue / Employee: 1.09B
• Employees: 284
• Market Cap: 20.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	305.54B	43.68B	16.68%
Jun 30, 2023	261.86B	70.54B	36.87%
Jun 30, 2022	191.32B	99.23B	107.76%
Jun 30, 2021	92.08B	1.56B	1.72%
Jun 30, 2020	90.52B	-25.22B	-21.79%